Viral Vectors & Vaccines

Chaired by:

Otto-Wilhelm Merten, PhD
Miltenyi Biotec Inc.

Nathalie A. Clément, PhD
Unicorn Consultations, LLC

J. Fraser Wright, PhD
Stanford University

Topics:

• Plasmid Development
• Producer Cell Lines
• Exosomes
• Upstream Process Development & Scale-Up
• Potency and High-Throughput Assays
• Downstream Process Development
• Formulation, Storage, and Stability
• Product Characterization
• Analytical Methods Development and Validation
• Application of Reference Standards & Materials

Cellular Therapies

Chaired by:

Martin A. Giedlin, PhD
Senti Biosciences

Mercedes Segura, PhD
ElevateBio

Topics:

• Assay Development
• Process Development and Characterization
• Product Characterization
• Cryopreservation (Starting Material and End Product)
• In-Process Monitoring
• Potency Assays
• Media Development
• Automation (Process and Assays)
• Tech Transfers
• Comparability
• iPSC-Derived Immune Cells
• Non-Viral Transfection
• Metabolic Assessment
• Apheresis Strategy
• Closed Manufacturing Systems

Baculovirus Expression Technology

Chaired by:

Dominic Esposito, PhD
Frederick National Laboratory
for Cancer Research

António M. Roldão, PhD
Instituto de Biologia Experimental e Tecnológica (iBET)

Topics:

• Human Vaccines: Large-Scale Production and Clinical Trials
• Veterinary Vaccines
• Baculoviruses as Insecticides
• Comparability Studies: BEVS Versus Other Expression Systems
• Baculovirus-Based Processes in Gene Therapy
• Advances in Structural Biology Using BEVS
• Synthetic Biology for BEVS Engineering
• Systems Biology for Bioprocess Engineering